• Explore /
  • Poster
  • / Multicenter, randomized phase II trial of physical activity (PA), metformin (Met), or the combination on metabolic biomarkers in stage I-III colorectal (CRC) and breast cancer (BC) survivors.

Multicenter, randomized phase II trial of physical activity (PA), metformin (Met), or the combination on metabolic biomarkers in stage I-III colorectal (CRC) and breast cancer (BC) survivors.

Abstract Poster

Authors

null

Jeffrey A. Meyerhardt

Dana-Farber Cancer Institute/Partners CancerCare, Boston, MA

Jeffrey A. Meyerhardt , Melinda L Irwin , Lee Jones , Sui Zhang , Nancy Campbell , Justin C. Brown , Michael N. Pollak , Alexandra Sorrentino , Brenda Cartmel , Maura Harrigan , Miranda West , Sara M. Tolaney , Rachel Lynn Yung , Eric P. Winer , Kimmie Ng , Thomas Adam Abrams , Charles S. Fuchs , Tara Beth Sanft , Pamela Douglas , Jennifer A. Ligibel

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Patient and Survivor Care

Track

Patient and Survivor Care

Sub Track

Survivorship

Clinical Trial Registration Number

NCT01340300

Citation

J Clin Oncol 35, 2017 (suppl; abstr 10059)

DOI

10.1200/JCO.2017.35.15_suppl.10059

Abstract #

10059

Poster Bd #

48

Abstract Disclosures

Similar Posters

First Author: Wendy Demark-Wahnefried

First Author: Heather Greenlee

First Author: Tarek Mohamed Ahmed Abdel-Fatah

First Author: Bob T. Li